The University of Chicago Header Logo

James Millis

Concepts (555)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Liver Transplantation
90
2022
1267
6.240
Why?
Islets of Langerhans Transplantation
12
2021
225
1.560
Why?
Immunosuppressive Agents
29
2021
977
1.560
Why?
Living Donors
14
2022
339
1.520
Why?
Graft Rejection
39
2014
1065
1.420
Why?
Hepatectomy
12
2011
166
1.420
Why?
Liver Diseases
11
2014
238
1.340
Why?
Tacrolimus
19
2014
373
1.250
Why?
Portal Vein
7
2018
120
1.140
Why?
Graft Survival
31
2018
884
1.070
Why?
Tissue Donors
12
2016
463
1.020
Why?
Postoperative Complications
22
2022
2207
0.960
Why?
Liver Neoplasms
12
2010
735
0.950
Why?
Kidney Transplantation
24
2012
849
0.910
Why?
Tissue and Organ Procurement
10
2022
311
0.890
Why?
Surgical Mesh
4
2007
116
0.860
Why?
Pancreas Transplantation
10
2006
103
0.850
Why?
Hepatic Artery
7
2006
83
0.800
Why?
Organ Transplantation
5
2017
265
0.790
Why?
Humans
160
2022
86601
0.760
Why?
Islets of Langerhans
6
2018
544
0.680
Why?
Liver, Artificial
4
2002
7
0.670
Why?
Quality Improvement
1
2022
428
0.660
Why?
Liver Failure
4
2004
78
0.650
Why?
Adult
75
2021
25640
0.610
Why?
Abdominal Cavity
2
2007
18
0.610
Why?
Hernia, Inguinal
2
2006
67
0.510
Why?
End Stage Liver Disease
1
2015
61
0.500
Why?
Child
42
2022
6926
0.490
Why?
Wounds, Gunshot
2
2021
71
0.470
Why?
Muromonab-CD3
11
1998
69
0.450
Why?
Follow-Up Studies
26
2018
3636
0.450
Why?
Insulin-Secreting Cells
4
2019
397
0.440
Why?
Cyclosporine
10
1998
234
0.440
Why?
Liver
11
2022
1229
0.440
Why?
Sirolimus
1
2014
169
0.440
Why?
Hepatocytes
3
2002
127
0.430
Why?
Male
74
2021
40956
0.430
Why?
Female
67
2022
44507
0.420
Why?
Polyethylene Glycols
2
2014
363
0.420
Why?
Prostheses and Implants
2
2010
121
0.400
Why?
Intestines
1
2014
411
0.400
Why?
Veterans
1
2011
72
0.390
Why?
Diabetes Mellitus, Type 1
5
2021
567
0.380
Why?
T-Lymphocytes, Regulatory
4
2014
295
0.370
Why?
Stents
4
2021
377
0.360
Why?
Obesity
2
2019
963
0.360
Why?
Duodenum
3
2006
100
0.350
Why?
Lysine
1
2010
147
0.350
Why?
Child, Preschool
26
2016
3611
0.350
Why?
Middle Aged
47
2021
25017
0.340
Why?
Time Factors
28
2015
5209
0.340
Why?
Jaundice, Obstructive
1
2008
10
0.330
Why?
Crohn Disease
2
2014
730
0.320
Why?
Carcinoma, Hepatocellular
6
2010
383
0.320
Why?
Jejunum
2
2006
79
0.320
Why?
Liver Abscess
1
2007
12
0.310
Why?
Treatment Outcome
20
2015
7988
0.310
Why?
Fasting
2
2018
161
0.310
Why?
Silicones
1
2007
16
0.310
Why?
Dimethylpolysiloxanes
1
2007
15
0.310
Why?
Hemangioma, Cavernous
1
2008
69
0.310
Why?
Pyelonephritis, Xanthogranulomatous
1
2007
3
0.310
Why?
Health Care Reform
1
2008
90
0.300
Why?
Minocycline
1
2007
15
0.300
Why?
Duodenal Diseases
1
2007
24
0.300
Why?
Liver Failure, Acute
1
2007
38
0.290
Why?
Infant
21
2015
3045
0.290
Why?
Patient Selection
3
2020
685
0.290
Why?
Kidney
5
2007
1241
0.290
Why?
Diverticulum
1
2007
44
0.290
Why?
Rectal Diseases
1
2006
24
0.290
Why?
Anti-Bacterial Agents
3
2007
746
0.290
Why?
Bacterial Infections
2
2005
182
0.280
Why?
Portasystemic Shunt, Transjugular Intrahepatic
4
2005
40
0.280
Why?
Adolescent
30
2021
8979
0.280
Why?
Tendons
1
2006
44
0.280
Why?
Colonic Diseases
1
2006
65
0.280
Why?
Peritoneal Dialysis, Continuous Ambulatory
1
2005
10
0.270
Why?
Foreign Bodies
1
2006
63
0.270
Why?
Bioprosthesis
1
2005
36
0.270
Why?
Hepatic Veins
2
2002
27
0.270
Why?
Antiviral Agents
3
2022
510
0.270
Why?
Retrospective Studies
30
2016
8475
0.270
Why?
Anesthesia, Local
1
2005
27
0.270
Why?
Ileostomy
1
2005
30
0.270
Why?
Prosthesis-Related Infections
1
2005
58
0.260
Why?
Graft Occlusion, Vascular
3
2002
99
0.250
Why?
Transplantation, Homologous
17
2013
996
0.250
Why?
Prosthesis Implantation
1
2005
125
0.240
Why?
Cyclic GMP
1
2004
58
0.240
Why?
Catheterization
1
2005
232
0.240
Why?
Pancreatitis, Chronic
2
2015
49
0.240
Why?
Survival Rate
15
2014
1860
0.240
Why?
Pancreas
4
2018
239
0.240
Why?
Morbidity
2
2022
148
0.230
Why?
Prospective Studies
12
2021
4210
0.230
Why?
Extracorporeal Circulation
1
2002
26
0.230
Why?
Bile Ducts
2
2002
59
0.230
Why?
Ultrasonography, Doppler
2
2002
80
0.220
Why?
Blood Loss, Surgical
2
2001
112
0.220
Why?
Cholecystectomy
1
2002
18
0.220
Why?
China
4
2015
228
0.220
Why?
Pancreatectomy
3
2018
148
0.210
Why?
Cannabidiol
1
2022
7
0.210
Why?
Thrombosis
4
2002
296
0.210
Why?
Rectus Abdominis
2
2013
37
0.210
Why?
Abdominal Wall
2
2013
30
0.210
Why?
Mortality
1
2022
149
0.200
Why?
Head Injuries, Penetrating
1
2022
54
0.200
Why?
Hepatitis C
4
2012
208
0.200
Why?
Monitoring, Physiologic
1
2002
268
0.200
Why?
Vascularized Composite Allotransplantation
1
2021
13
0.190
Why?
Perfusion
2
2022
203
0.190
Why?
Hypertension, Portal
3
1998
47
0.190
Why?
Intraoperative Complications
1
2002
185
0.190
Why?
Brain Injuries, Traumatic
1
2022
86
0.190
Why?
Prognosis
8
2018
3674
0.190
Why?
Policy
1
2020
34
0.180
Why?
Biliary Tract Diseases
2
1997
34
0.180
Why?
Prisoners
2
2011
40
0.180
Why?
Thrombectomy
1
2021
158
0.180
Why?
Host-Pathogen Interactions
1
2022
231
0.180
Why?
Vena Cava, Inferior
1
2021
143
0.180
Why?
Waiting Lists
4
2007
175
0.180
Why?
Bile Duct Neoplasms
2
2018
79
0.180
Why?
Hepatitis B
5
2010
74
0.180
Why?
CD4-Positive T-Lymphocytes
2
2012
425
0.170
Why?
Reperfusion Injury
2
1997
131
0.170
Why?
Biological Products
1
2021
143
0.170
Why?
HIV Infections
3
2012
772
0.170
Why?
Informed Consent
3
2011
266
0.170
Why?
Absorptiometry, Photon
1
2019
99
0.160
Why?
Reoperation
15
1999
597
0.160
Why?
Immunity, Innate
1
2022
409
0.160
Why?
Health Policy
2
2011
180
0.160
Why?
Anastomosis, Surgical
4
2006
267
0.160
Why?
Laparoscopy
1
2005
754
0.160
Why?
Amino Acid Metabolism, Inborn Errors
1
1998
11
0.160
Why?
Venous Thrombosis
1
2021
243
0.160
Why?
Urea
1
1998
57
0.160
Why?
Ammonia
1
1998
37
0.160
Why?
Donor Selection
2
2018
67
0.160
Why?
Cultural Characteristics
2
2015
19
0.160
Why?
Body Mass Index
2
2019
770
0.150
Why?
Kidney Failure, Chronic
3
2010
509
0.150
Why?
Tomography, X-Ray Computed
4
2008
2600
0.150
Why?
Gallbladder
1
1997
30
0.150
Why?
Occlusive Dressings
1
1996
7
0.150
Why?
Laparotomy
2
2007
59
0.150
Why?
Chicago
5
2021
1379
0.150
Why?
Polytetrafluoroethylene
1
1996
74
0.140
Why?
Cyclosporins
6
1991
59
0.140
Why?
Biliary Atresia
4
1995
22
0.140
Why?
Cholangiocarcinoma
3
2010
66
0.140
Why?
Liver Cirrhosis
4
2010
297
0.140
Why?
Antibodies, Monoclonal
5
2004
1376
0.140
Why?
Stomach
2
2006
108
0.140
Why?
Tissue Preservation
1
2015
14
0.130
Why?
Gift Giving
1
2015
5
0.130
Why?
Social Control, Formal
1
2015
12
0.130
Why?
Volition
1
2015
15
0.130
Why?
Steroids
1
1996
177
0.130
Why?
Pentanoic Acids
1
2014
6
0.130
Why?
United States
8
2021
6665
0.130
Why?
Cholangitis, Sclerosing
2
2013
52
0.130
Why?
Biotin
1
2014
44
0.120
Why?
Mixed Tumor, Malignant
1
1994
3
0.120
Why?
International Agencies
1
2014
34
0.120
Why?
Universities
1
2015
135
0.120
Why?
Surface-Active Agents
1
2014
59
0.120
Why?
Body Height
1
2014
99
0.120
Why?
Carcinosarcoma
1
1994
20
0.120
Why?
Colectomy
3
2007
167
0.120
Why?
Mycophenolic Acid
3
1998
87
0.120
Why?
Aged
14
2016
18402
0.120
Why?
Transplantation Immunology
1
2014
84
0.120
Why?
Health Behavior
1
2015
183
0.120
Why?
Surgical Flaps
2
2013
241
0.120
Why?
Heart Transplantation
6
2008
705
0.110
Why?
Tissue and Organ Harvesting
2
2007
78
0.110
Why?
Morphogenesis
1
2014
192
0.110
Why?
Cadaver
4
2002
185
0.110
Why?
Cryopreservation
1
2013
68
0.110
Why?
Liver Function Tests
3
1997
93
0.110
Why?
Monitoring, Immunologic
1
2012
17
0.110
Why?
International Cooperation
2
2011
127
0.110
Why?
Opportunistic Infections
2
2010
59
0.110
Why?
Capital Punishment
1
2011
3
0.110
Why?
Animals
13
2022
26581
0.100
Why?
Antigens, Differentiation, T-Lymphocyte
2
1989
95
0.100
Why?
Rats, Inbred Lew
3
2010
186
0.100
Why?
Coinfection
1
2012
58
0.100
Why?
Hepatoblastoma
2
2010
12
0.100
Why?
Models, Theoretical
1
2014
482
0.100
Why?
Immunologic Factors
1
2013
170
0.100
Why?
Anti-Inflammatory Agents
2
2013
339
0.100
Why?
Pancreatic Neoplasms
2
1994
645
0.100
Why?
Liver Regeneration
1
2011
32
0.100
Why?
Death
1
2011
73
0.100
Why?
Tumor Virus Infections
2
2005
81
0.100
Why?
Platelet Count
1
2011
92
0.100
Why?
Fascia
1
2010
30
0.100
Why?
Hepatitis C, Chronic
1
2012
126
0.100
Why?
Hyperoxaluria
1
2010
26
0.100
Why?
Hemangioendothelioma
1
2010
9
0.100
Why?
Hepatic Encephalopathy
2
2001
40
0.100
Why?
Survival Analysis
8
2012
1538
0.100
Why?
Incidence
6
2012
1576
0.100
Why?
Alginates
1
2010
15
0.090
Why?
Capsules
1
2010
38
0.090
Why?
Polylysine
1
2010
33
0.090
Why?
Health Knowledge, Attitudes, Practice
1
2015
508
0.090
Why?
Gene Expression Regulation
1
2019
1920
0.090
Why?
Tumor Necrosis Factor-alpha
5
1991
683
0.090
Why?
Costs and Cost Analysis
3
2021
153
0.090
Why?
Transplantation Tolerance
1
2011
130
0.090
Why?
Young Adult
6
2019
5974
0.090
Why?
Enterococcus
2
2001
35
0.090
Why?
Antibodies
4
2000
350
0.090
Why?
Radiography
3
2007
813
0.090
Why?
Receptors, Antigen, T-Cell
2
1989
372
0.090
Why?
Dose-Response Relationship, Drug
1
2014
1961
0.090
Why?
Resuscitation
2
2022
100
0.090
Why?
Interferon-gamma
1
2011
444
0.090
Why?
ABO Blood-Group System
2
2008
62
0.090
Why?
Drug Compounding
1
2010
78
0.090
Why?
Age Factors
5
2019
1849
0.090
Why?
Neuroendocrine Tumors
1
2010
105
0.080
Why?
Sarcoma
1
2010
211
0.080
Why?
Sensitivity and Specificity
3
2019
1990
0.080
Why?
Organ Preservation
3
2022
83
0.080
Why?
Illinois
2
2002
462
0.080
Why?
Documentation
1
2009
98
0.080
Why?
Chemoembolization, Therapeutic
1
2008
36
0.080
Why?
Blood Group Incompatibility
1
2008
18
0.080
Why?
Amikacin
1
2007
5
0.080
Why?
C-Peptide
2
2018
174
0.080
Why?
Ciprofloxacin
1
2007
29
0.080
Why?
Guanine
1
2008
208
0.080
Why?
Lymphoproliferative Disorders
3
2001
107
0.080
Why?
Rats
6
2010
3990
0.080
Why?
Body Weight
2
2014
459
0.080
Why?
Biopsy
5
1999
1161
0.080
Why?
Iliac Vein
1
2007
30
0.070
Why?
Acne Vulgaris
1
2007
32
0.070
Why?
Iliac Artery
1
2007
35
0.070
Why?
Pseudomonas Infections
1
2007
95
0.070
Why?
Health Care Rationing
2
2004
83
0.070
Why?
Prednisone
5
1998
258
0.070
Why?
Rare Diseases
1
2007
59
0.070
Why?
Splenic Artery
1
2006
11
0.070
Why?
Creatinine
5
1999
338
0.070
Why?
Length of Stay
3
2001
700
0.070
Why?
Kidney Diseases
3
2005
418
0.070
Why?
Medical Oncology
1
2010
359
0.070
Why?
Aorta, Abdominal
1
2006
60
0.070
Why?
Pressure
1
2007
165
0.070
Why?
Intestinal Perforation
1
2006
34
0.070
Why?
Ethics, Medical
1
2009
306
0.070
Why?
Pseudomonas aeruginosa
1
2007
194
0.070
Why?
Neoplasm Metastasis
1
2010
1056
0.070
Why?
Polypropylenes
1
2005
23
0.070
Why?
Transplantation, Autologous
2
2018
330
0.070
Why?
Risk Assessment
2
2019
2261
0.070
Why?
Anal Canal
1
2006
89
0.070
Why?
Necrosis
1
2006
204
0.070
Why?
Biopsy, Needle
3
1998
235
0.070
Why?
Blood Glucose
3
2018
873
0.070
Why?
Risk Factors
10
2012
5416
0.070
Why?
Anesthesia, General
1
2006
114
0.070
Why?
Chronic Disease
4
2008
970
0.070
Why?
Drug Resistance
2
1996
256
0.070
Why?
BK Virus
1
2005
23
0.070
Why?
Polyomavirus Infections
1
2005
28
0.060
Why?
Isoxazoles
1
2005
77
0.060
Why?
Disease Susceptibility
1
2005
193
0.060
Why?
Acute Disease
4
1999
826
0.060
Why?
Nephrectomy
1
2007
294
0.060
Why?
Cohort Studies
3
2018
2767
0.060
Why?
Mice
4
2022
11352
0.060
Why?
California
3
1997
138
0.060
Why?
Biocompatible Materials
1
2005
193
0.060
Why?
Cell Separation
1
2004
196
0.060
Why?
Membrane Proteins
1
2010
1196
0.060
Why?
Diabetes Mellitus, Type 2
1
2013
1373
0.060
Why?
Surgical Procedures, Operative
1
2005
182
0.060
Why?
Cell Culture Techniques
1
2004
188
0.060
Why?
Hospitals, University
3
1999
194
0.060
Why?
Thermodynamics
1
2004
309
0.060
Why?
Canada
2
2007
204
0.060
Why?
Decision Support Techniques
1
2004
160
0.060
Why?
Pain, Postoperative
1
2005
240
0.060
Why?
Organ Size
2
2014
364
0.060
Why?
Temperature
1
2004
396
0.060
Why?
Cell Line, Transformed
1
2002
154
0.060
Why?
Adrenal Cortex Hormones
2
1998
263
0.050
Why?
Virus Replication
2
2022
319
0.050
Why?
Intracranial Pressure
1
2002
77
0.050
Why?
Colorectal Neoplasms
2
2000
938
0.050
Why?
Antilymphocyte Serum
5
2004
71
0.050
Why?
Biomarkers, Tumor
1
2010
1464
0.050
Why?
Bilirubin
3
1999
125
0.050
Why?
Regional Blood Flow
1
2002
197
0.050
Why?
A549 Cells
1
2022
39
0.050
Why?
Aged, 80 and over
3
2013
6501
0.050
Why?
Iatrogenic Disease
1
2002
69
0.050
Why?
Vero Cells
1
2022
100
0.050
Why?
Virus Internalization
1
2022
39
0.050
Why?
Cardiotonic Agents
1
2002
87
0.050
Why?
Constriction, Pathologic
1
2002
213
0.050
Why?
Drug Administration Schedule
4
1998
916
0.050
Why?
Respiratory Insufficiency
2
2001
150
0.050
Why?
Cholecystectomy, Laparoscopic
1
2002
50
0.050
Why?
Insulin
3
2018
1160
0.050
Why?
Vancomycin Resistance
1
2001
18
0.050
Why?
Endoplasmic Reticulum Stress
1
2022
83
0.050
Why?
Gene Expression Regulation, Viral
1
2022
90
0.050
Why?
Constriction
1
2001
27
0.050
Why?
Interferons
1
2022
133
0.050
Why?
Biological Availability
2
1998
92
0.050
Why?
Cerebrovascular Circulation
1
2002
212
0.050
Why?
Bile
2
2001
57
0.050
Why?
Severity of Illness Index
1
2007
1801
0.050
Why?
Endoribonucleases
1
2022
92
0.050
Why?
Hepatitis, Autoimmune
1
2001
19
0.050
Why?
Positive-Pressure Respiration
1
2001
41
0.050
Why?
Foreign-Body Migration
1
2001
35
0.050
Why?
Antimetabolites
1
2000
24
0.050
Why?
Biliary Tract Neoplasms
1
2000
33
0.050
Why?
Immunotherapy
2
1999
629
0.050
Why?
Heart Rate
1
2002
492
0.050
Why?
Neurosurgical Procedures
1
2022
213
0.050
Why?
Respiratory Tract Diseases
1
2000
45
0.050
Why?
Computed Tomography Angiography
1
2021
131
0.040
Why?
Autoantibodies
1
2001
267
0.040
Why?
Intraoperative Period
2
1997
90
0.040
Why?
Transplantation, Heterologous
1
2021
363
0.040
Why?
Hepatitis, Alcoholic
1
1999
19
0.040
Why?
Fatal Outcome
2
2010
293
0.040
Why?
Cell Transplantation
1
1999
47
0.040
Why?
Mice, Nude
1
2021
790
0.040
Why?
Program Evaluation
1
2000
297
0.040
Why?
Emulsions
1
1998
19
0.040
Why?
North America
1
2018
180
0.040
Why?
Nutrition Surveys
1
2019
114
0.040
Why?
Carbamoyl-Phosphate Synthase (Ammonia)
1
1998
4
0.040
Why?
Cytokines
1
2022
776
0.040
Why?
Ornithine Carbamoyltransferase Deficiency Disease
1
1998
4
0.040
Why?
Citrulline
1
1998
10
0.040
Why?
Communication Disorders
1
1998
7
0.040
Why?
Diagnosis, Differential
3
2010
1565
0.040
Why?
Anticoagulants
1
2001
408
0.040
Why?
Neoplasm Recurrence, Local
2
2001
1313
0.040
Why?
Epithelial Cells
1
2022
669
0.040
Why?
Alcoholism
1
1999
172
0.040
Why?
Gram-Positive Bacterial Infections
1
1998
47
0.040
Why?
Microcephaly
1
1998
75
0.040
Why?
Vancomycin
1
1998
72
0.040
Why?
Multivariate Analysis
3
2010
999
0.040
Why?
Glucose Tolerance Test
1
2018
228
0.040
Why?
Coccidioidomycosis
1
1997
7
0.040
Why?
Genetic Therapy
1
1999
342
0.040
Why?
Blood Pressure
1
2002
1143
0.040
Why?
Dosage Forms
1
1996
7
0.040
Why?
Intellectual Disability
1
1998
186
0.040
Why?
Methylprednisolone
1
1996
66
0.040
Why?
Double-Blind Method
1
2021
1823
0.040
Why?
Cardiac Surgical Procedures
1
2001
462
0.030
Why?
Syndrome
1
1997
446
0.030
Why?
Herpesvirus 4, Human
1
1996
114
0.030
Why?
Quality of Life
3
1996
1583
0.030
Why?
Oxygen
1
2001
726
0.030
Why?
Situs Inversus
1
1995
13
0.030
Why?
Sex Factors
1
2019
1054
0.030
Why?
Pancreatic Function Tests
1
2015
7
0.030
Why?
Somatostatin-Secreting Cells
1
2015
7
0.030
Why?
Glucagon-Secreting Cells
1
2015
25
0.030
Why?
Public Opinion
1
2015
43
0.030
Why?
Logistic Models
1
2018
1185
0.030
Why?
Altruism
1
2015
35
0.030
Why?
Hepatitis, Viral, Human
2
1999
25
0.030
Why?
Administration, Oral
1
1996
684
0.030
Why?
Carbocyanines
1
2014
18
0.030
Why?
Succinimides
1
2014
13
0.030
Why?
Streptavidin
1
2014
14
0.030
Why?
Tissue Survival
1
2014
13
0.030
Why?
Intestine, Small
1
1996
303
0.030
Why?
Tissue Culture Techniques
1
2014
79
0.030
Why?
Age of Onset
1
2015
310
0.030
Why?
Feasibility Studies
2
2011
751
0.030
Why?
Cell Communication
1
2014
194
0.030
Why?
Celiac Plexus
1
1993
3
0.030
Why?
Hepatitis B virus
2
2008
43
0.030
Why?
Leiomyosarcoma
1
1994
40
0.030
Why?
Nerve Compression Syndromes
1
1993
18
0.030
Why?
Family
1
1995
311
0.030
Why?
Enzyme-Linked Immunosorbent Assay
2
2011
376
0.030
Why?
Interleukin-2 Receptor alpha Subunit
1
2013
36
0.030
Why?
Pilot Projects
2
2011
839
0.030
Why?
Swine
1
2014
555
0.030
Why?
Recurrence
4
1998
1139
0.030
Why?
Cell Adhesion
1
2014
420
0.030
Why?
Cell- and Tissue-Based Therapy
1
2013
49
0.030
Why?
Hemorrhage
2
2000
268
0.030
Why?
C-Reactive Protein
1
2013
190
0.030
Why?
Azathioprine
3
1998
125
0.030
Why?
Abdomen, Acute
1
2012
20
0.030
Why?
T-Lymphocytes
2
1989
1195
0.030
Why?
Cholestasis
1
1992
47
0.030
Why?
Academic Medical Centers
1
1995
379
0.030
Why?
Medical Tourism
1
2011
5
0.030
Why?
Forkhead Transcription Factors
1
2013
166
0.030
Why?
CD3 Complex
2
1989
135
0.030
Why?
Immunoassay
1
2012
92
0.030
Why?
Leukocytes, Mononuclear
1
2013
196
0.030
Why?
Enzyme-Linked Immunospot Assay
1
2011
7
0.030
Why?
Drainage
3
1998
157
0.030
Why?
Immunity, Cellular
1
2012
177
0.030
Why?
Inflammatory Bowel Diseases
1
1998
549
0.030
Why?
Advisory Committees
1
2011
90
0.020
Why?
Algorithms
2
2014
1830
0.020
Why?
Colitis, Ulcerative
2
2013
711
0.020
Why?
Hepacivirus
1
2012
159
0.020
Why?
AIDS-Related Opportunistic Infections
1
2010
33
0.020
Why?
Brain Death
1
2011
69
0.020
Why?
CD4 Lymphocyte Count
1
2010
66
0.020
Why?
alpha-Fetoproteins
1
2010
45
0.020
Why?
Drug Therapy, Combination
3
1998
894
0.020
Why?
Immunohistochemistry
1
2015
1753
0.020
Why?
Chemoprevention
1
2010
91
0.020
Why?
Hypertonic Solutions
1
1990
17
0.020
Why?
Abdomen
1
2010
122
0.020
Why?
Organ Preservation Solutions
1
1990
28
0.020
Why?
Diabetes Mellitus
1
1998
806
0.020
Why?
Solutions
1
1990
85
0.020
Why?
In Vitro Techniques
1
2011
989
0.020
Why?
Adenocarcinoma
2
1994
1169
0.020
Why?
Predictive Value of Tests
1
2014
1673
0.020
Why?
Blood Transfusion
1
1990
157
0.020
Why?
Kidney Tubular Necrosis, Acute
2
1999
10
0.020
Why?
Portasystemic Shunt, Surgical
1
1989
12
0.020
Why?
Antibodies, Anti-Idiotypic
1
1989
44
0.020
Why?
Portoenterostomy, Hepatic
1
1988
3
0.020
Why?
Rupture
1
2008
63
0.020
Why?
Random Allocation
1
1989
332
0.020
Why?
Aspergillosis
1
1988
41
0.020
Why?
Kaplan-Meier Estimate
1
2010
860
0.020
Why?
Proportional Hazards Models
1
2010
857
0.020
Why?
Methylprednisolone Hemisuccinate
2
1998
10
0.020
Why?
DNA, Viral
1
2008
265
0.020
Why?
Infant, Newborn
3
1998
2378
0.020
Why?
Mice, Inbred C57BL
1
2014
3092
0.020
Why?
Cell Differentiation
1
1994
1458
0.020
Why?
Image Processing, Computer-Assisted
1
2013
1204
0.020
Why?
Neoplasm Proteins
1
2010
532
0.020
Why?
Rats, Inbred BUF
3
1991
4
0.020
Why?
Los Angeles
2
1996
28
0.020
Why?
Angiography
1
2006
208
0.020
Why?
Crotonates
1
2005
11
0.020
Why?
Toluidines
1
2005
17
0.020
Why?
Hydroxybutyrates
1
2005
27
0.020
Why?
Combined Modality Therapy
3
1995
1685
0.020
Why?
Aniline Compounds
1
2005
55
0.020
Why?
Nitriles
1
2005
149
0.020
Why?
Receptors, Interleukin-2
1
2004
66
0.020
Why?
Esophageal and Gastric Varices
2
1998
33
0.020
Why?
Urinary Bladder
2
1996
246
0.020
Why?
Lymphocyte Depletion
1
2004
97
0.020
Why?
Small-Area Analysis
1
2003
8
0.020
Why?
Health Priorities
1
2003
23
0.010
Why?
Clinical Trials as Topic
1
1989
1169
0.010
Why?
Geography
1
2003
223
0.010
Why?
Neoplasm Staging
2
2000
1937
0.010
Why?
African Americans
1
2001
10
0.010
Why?
Evidence-Based Medicine
1
2004
429
0.010
Why?
Environmental Microbiology
1
2001
22
0.010
Why?
Gastrointestinal Hemorrhage
2
1998
229
0.010
Why?
Portal System
1
2001
13
0.010
Why?
Focal Nodular Hyperplasia
1
2001
8
0.010
Why?
Government Regulation
1
2001
49
0.010
Why?
Hamartoma
1
2001
31
0.010
Why?
Models, Statistical
1
2004
574
0.010
Why?
Cytomegalovirus Infections
1
2001
144
0.010
Why?
DNA, Bacterial
1
2001
236
0.010
Why?
Hemangioma
1
2001
60
0.010
Why?
Rats, Inbred Strains
2
1990
312
0.010
Why?
Lymphotoxin-alpha
2
1990
44
0.010
Why?
Alanine Transaminase
2
1990
73
0.010
Why?
Aspartate Aminotransferases
2
1990
73
0.010
Why?
Population Surveillance
1
2001
219
0.010
Why?
Fibrosis
1
2001
203
0.010
Why?
Cysts
1
2001
104
0.010
Why?
Feces
1
2001
319
0.010
Why?
Risk
1
2001
674
0.010
Why?
Cell Division
1
2001
696
0.010
Why?
Autoimmune Diseases
1
2001
241
0.010
Why?
Radiography, Thoracic
1
2001
320
0.010
Why?
Adenoma
1
2001
235
0.010
Why?
Plasmapheresis
1
1998
26
0.010
Why?
Pregnancy
2
2001
2893
0.010
Why?
Pneumonia
1
2000
179
0.010
Why?
Drug Resistance, Microbial
1
1998
72
0.010
Why?
Gallbladder Diseases
1
1998
22
0.010
Why?
Aminosalicylic Acids
1
1998
42
0.010
Why?
Pregnancy Complications
1
2001
336
0.010
Why?
Lung Diseases
1
2000
263
0.010
Why?
Complement C3
1
1997
58
0.010
Why?
Urinary Retention
1
1997
40
0.010
Why?
Radiology, Interventional
1
1998
68
0.010
Why?
Actuarial Analysis
1
1997
66
0.010
Why?
Fluconazole
1
1997
10
0.010
Why?
Fibrin
1
1997
84
0.010
Why?
Amphotericin B
1
1997
34
0.010
Why?
Renal Insufficiency
1
1998
114
0.010
Why?
Bacteremia
1
1998
99
0.010
Why?
Capillaries
1
1997
91
0.010
Why?
Kidney Glomerulus
1
1997
123
0.010
Why?
Histocompatibility Testing
1
1996
154
0.010
Why?
Treatment Failure
1
1997
285
0.010
Why?
Neutrophils
1
1997
307
0.010
Why?
Bone Diseases
1
1995
54
0.010
Why?
Immunoglobulin G
1
1997
456
0.010
Why?
Salvage Therapy
1
1996
233
0.010
Why?
Safety
1
1995
152
0.010
Why?
Glucocorticoids
1
1997
352
0.010
Why?
Extremities
1
1995
165
0.010
Why?
Immunization, Passive
1
1994
71
0.010
Why?
Emergencies
1
1995
113
0.010
Why?
Postoperative Care
1
1995
221
0.010
Why?
Carcinoma, Neuroendocrine
1
1993
28
0.010
Why?
Ischemia
1
1995
243
0.010
Why?
Diabetic Nephropathies
1
1995
248
0.010
Why?
Choledochostomy
1
1992
8
0.010
Why?
Anastomosis, Roux-en-Y
1
1992
26
0.010
Why?
Cholestasis, Intrahepatic
1
1992
17
0.010
Why?
Therapeutic Irrigation
1
1992
60
0.010
Why?
Dilatation
1
1992
48
0.010
Why?
Immune Sera
1
1991
52
0.010
Why?
Adenoma, Bile Duct
1
1990
4
0.010
Why?
Rats, Inbred BN
1
1990
37
0.010
Why?
Immunologic Techniques
1
1990
27
0.010
Why?
Transplantation, Isogeneic
1
1990
39
0.010
Why?
Raffinose
1
1990
24
0.010
Why?
Leukocyte Count
1
1990
220
0.010
Why?
Glutathione
1
1990
104
0.010
Why?
Allopurinol
1
1990
80
0.010
Why?
Recombinant Proteins
1
1991
1014
0.010
Why?
Evaluation Studies as Topic
1
1989
274
0.010
Why?
Cardiovascular Diseases
1
1995
827
0.010
Why?
Analysis of Variance
1
1990
912
0.010
Why?
Occupations
1
1988
26
0.000
Why?
Adenosine
1
1990
225
0.000
Why?
Activities of Daily Living
1
1988
204
0.000
Why?
Patient Acceptance of Health Care
1
1988
238
0.000
Why?
Millis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (555)
Explore
_
Co-Authors (59)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_